These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7252750)

  • 1. Oxytocinase versus estriol for the assessment of fetal well-being.
    Blum M
    J Perinat Med; 1981; 9(3):145-9. PubMed ID: 7252750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of human placental lactogen, oxytocinase and estriol in twin pregnancies with intrauterine growth retardation.
    Briët JW; Hoorn RK
    Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):7-14. PubMed ID: 7060818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAP, HCS and urinary estriol measurements in risk pregnancies--a comparative study.
    Rydén G; Kågedal B
    J Perinat Med; 1977; 5(6):244-51. PubMed ID: 611164
    [No Abstract]   [Full Text] [Related]  

  • 4. [Examination of serum oxytocinase activity and estriol in 24-hour urine in prolonged gestation (author's transl)].
    Seban J; Pociatek A; Vierik J; Bruchác D; Patorcevová I; Gubza S
    Bratisl Lek Listy; 1982 Apr; 77(4):444-8. PubMed ID: 7093753
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of oxytocinase in obstetrics].
    Nalepa I
    Ginekol Pol; 1986 Oct; 57(10):669-71. PubMed ID: 3817572
    [No Abstract]   [Full Text] [Related]  

  • 6. Human chorionic somatomammotropin, estriol and oxytocinase as indexes of fetal growth.
    Giussi G; Vinacur J; Ballejo G; Garófalo EG; Martino I
    J Perinat Med; 1979; 7(5):235-42. PubMed ID: 501507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCS, estriol and oxytocinase in maternal serum and neonatal condition in high risk pregnancies.
    Giussi G; Ballejo G; Marinho E; Xercavins J; Vinacur J; Nieto F; Roca R; Rieppi G
    J Perinat Med; 1979; 7(5):243-9. PubMed ID: 501508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scoring system for the assessment of multiple methods of monitoring fetal growth.
    Robinson HP; Chatfield WR; Logan RW; Tweedie AK; Barnard WP
    J Obstet Gynaecol Br Commonw; 1973 Mar; 80(3):230-5. PubMed ID: 4703261
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of the determination of oxytocinase in monitoring late pregnancy.
    Klimek R; Bacz A; Kowalczyk B; Zywar R; Bałajewicz M
    Ginekol Pol; 1984 Feb; 55(2):101-7. PubMed ID: 6469029
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures].
    Kyank HR
    Zentralbl Gynakol; 1983; 105(10):635-41. PubMed ID: 6880465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between plasma unconjugated oestriol and cystine aminopeptidase concentrations and uterine contractions.
    Hull MG; Monro PP; Ellis BW
    Br J Obstet Gynaecol; 1979 Mar; 86(3):180-5. PubMed ID: 427059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Concentrations of total oestriol, non-conjugated oestriol, human placental lactogen and oxytocinase in the serum, and total oestrogens in the urine of pregnant women, following the administration of betamethasone (author's transl)].
    Knoll E; Kayser A; Wisser H
    J Clin Chem Clin Biochem; 1978 Nov; 16(11):621-4. PubMed ID: 731194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Placental (HPL, HSAP, CAP) and fetal (estriol in urine and blood) parameters in high risk pregnancies].
    Battaglia GB; Morresi G; Coronella L; Messeri G; Valenza T
    Quad Sclavo Diagn; 1977 Dec; 13(4):434-48. PubMed ID: 351694
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical determination of plasma oxytocinase during pregnancy.
    Dottaviano EJ; Marino RC; Menegatto G
    Braz J Med Biol Res; 1987; 20(3-4):425-7. PubMed ID: 3451790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Further modification by Klimek of the chemical method of Tuppy and Nesvadba for determining cystyl aminopeptidase (oxytocinase) activity in the blood serum].
    Nalepa I; Gadek K
    Ginekol Pol; 1986 Sep; 57(9):622-5. PubMed ID: 3803988
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methods of serum enzyme determination and its clinical significance: cystine aminopeptidase].
    Kumasaka K; Sekiguchi M
    Rinsho Byori; 1983 Jun; Suppl 55():156-66. PubMed ID: 6655887
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of various chromogenic substrates for the determination of L-cystine aminopeptidase (serum oxytocinase, E.C.3.4.1.2)].
    Küllertz G; Neubert K; Resch B; Schönberner H
    Z Med Lab Diagn; 1982 Jun; 23(3):150-5. PubMed ID: 7136163
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activity of oxytocinase (cystine-aminopeptidase-CAP) in serum of pregnant women and uterus sensitivity to oxytocin and prostaglandin F2 alpha in cases of post-term birth (author's transl)].
    Urban J; Jóźwik M; Skrzypiec R; Chomański M; Brzostek G
    Zentralbl Gynakol; 1982; 104(7):422-6. PubMed ID: 6954806
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective assessment of tests of fetoplacental function.
    McDowell DR; Oliver RW; Best FA
    Ann Clin Biochem; 1982 Jan; 19(Pt 1):12-6. PubMed ID: 7065628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feto-placental system in diabetes mellitus and hydramnios].
    Savchenko ON; Kosheleva NG; Iartseva MA; Golumb SB; Stepanov GS
    Akush Ginekol (Mosk); 1991 Dec; (12):12-5. PubMed ID: 1789335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.